SCHEMBL5886600

SCHEMBL5886600

CS(=O)(=O)Nc1ccc2ccc3nc4ccccc4nc3c2c1NS(C)(=O)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.42
GLO1 Q04760 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C9 P11712 2/20 0.40
CASP1 P29466 2/20 0.40
CASP7 P55210 2/20 0.40
GLA P06280 2/20 0.39
TP53 P04637 2/20 0.39
RAB9A P51151 2/20 0.39
TOP2A P11388 2/20 0.39
TOP2B Q02880 2/20 0.39
HSD17B10 Q99714 2/20 0.39
SLC22A1 O15245 1/20 0.39
ABCC4 O15439 1/20 0.39
NR1I2 O75469 1/20 0.39
CYP3A4 P08684 1/20 0.39
CHRM1 P11229 1/20 0.39
TOP1 P11387 1/20 0.39
DRD2 P14416 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17187705 0.77 GLO1 (0.57) KDM1AGLO1CYP1A2CYP2D6CYP2C9
SCHEMBL5886403 0.77 ALDH1A1 (0.46) KDM1ACYP1A2CYP2D6CYP2C9CASP1
Phenazine SCHEMBL1750964 0.65 MAPT (0.58) KDM1ACYP1A2CYP2D6CYP2C9CASP1
SCHEMBL21489525 0.65 GLO1 (0.59) GLO1GLATP53RAB9ATSHR
SCHEMBL11209338 0.64 NQO2 (0.45) CYP1A2CYP2C9RAB9ATSHRALDH1A1
SCHEMBL10786542 0.64 ELANE (0.43) KDM1ARAB9AALDH1A1KDM4EHPGD
Sulfuric Acid SCHEMBL28762472 0.64 ALDH1A1 (0.41) CYP1A2CYP2D6CYP2C9CASP1CASP7
SCHEMBL31607195 0.63 ALDH1A1 (0.48) CYP1A2RAB9AHSD17B10CYP3A4TSHR
SCHEMBL2068498 0.63 KEAP1 (0.65) GLO1HSD17B10TSHRPTGS2ALDH1A1
SCHEMBL29904739 0.63 KEAP1 (0.65) GLO1HSD17B10TSHRPTGS2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7132419-B2 Pharmaceutical compounds XENOVA LIMITED (GB) 2006-11-07 US disclosed
US-20050143383-A1 Pharmaceutical compounds XENOVA LIMITED (GB) 2005-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143383-A1 Pharmaceutical compounds CHRNA10, OPRM1, SCN10A KDM1A 3135/4885GLO1 4318/4885CYP1A2 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.